Quick Summary:
In the rapidly evolving healthcare industry, the Hemostasis Diagnostic Devices and Equipment Market offers significant growth potential. With rising numbers of surgeries performed and an increasing incidence of diseases as the population ages, demand is high for devices that predict bleeding during surgery, optimize clotting, and provide crucial guidance for anticoagulation and transfusion in procedures.
Our comprehensive report delves into this highly relevant market, providing an in-depth analysis of the current industry scenario, key market players, trends and opportunities. From manufacturers and distributors to end customers, it presents invaluable insights for anyone involved in hemostasis diagnostics. The extensive market data and statistics will equip you with the crucial knowledge needed to navigate and succeed within this bustling marketplace.
Do not miss your chance to stay ahead in the hemostasis diagnostic devices and equipment market. Secure your copy of the report today, and gain the decisive edge in crafting effective business strategies tomorrow.
The global hemostasis diagnostic devices and equipment market will grow from $4.77 billion in 2022 to $5.4 billion in 2023 at a compound annual growth rate (CAGR) of 13.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services effecting many markets across the globe. The hemostasis diagnostic devices and equipment market is expected to grow to $8 billion in 2027 at a CAGR of 10.3%.
Hemostasis diagnostic devices and equipment consists of sales of instruments such as analyzers, coagulation instruments, other hemostasis instruments, and reagents and kits that are used in hemostasis diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
Hemostasis is the process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. With the help of hemostasis diagnostic devices, the cause of bleeding during surgery can be predicted by identifying any hemostatic defects in patients.
North America was the largest region in the hemostasis diagnostic devices and equipment market in 2022. Asia Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The main products of hemostasis diagnostic devices and equipment are analyzers, coagulation instruments, other hemostasis instruments, and reagents and kits. A hemostasis diagnostic analyzer is a tool utilized to predict the cause of bleeding during surgery by identifying any hemostatic defects. The hemostasis diagnostic devices and equipment are automated, semi-automated, and manual that is used by hospitals, clinics, independent diagnostic, laboratories, and others.
The increased likelihood of older people being diagnosed with a disease is driving the number of surgeries such as cardiovascular diseases (CVD), using hemostasis devices. Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries in elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery.
According to the American Heart Association report, Americans older than 80 have a high risk of devolving a cardiovascular disease (CVD), around 83% of men and 87.1% of females will be suffering from any form of CVD, therefore, to improve the comfort of the patient and the success rate of surgeries as a result hemostasis device has been implemented widely.
The use of hemostasis devices in hospitals or clinics requires a very lengthy approval procedure which is restraining the market. Before hemostasis devices can enter the market for commercial use they have to clear the regulations set by the Code of Federal Regulations (title 21). The process of approval consists firstly identification of the device, secondly classification of the device and finally, the date of the pre-market approval (PMA) or the notice of completion of prescription drug plan (PDP) is required. It is a very long and time-consuming approval process that discourages new entrants from entering this market. For example, Cardiva medical Inc. had to wait for a processing period of four months before they received approval to change the existing equipment with a newer and modern one.
The emergence of new and improved technology in the hemostasis diagnostic device and equipment market. To improve the quality and success rate of operations, new and improved technology such as the collagen vascular hemostasis devices have been implemented. Collagen is the main structural protein found in skin and other connective tissues. It is widely used in purified form for cosmetic surgical treatments and has now emerged in the hemostasis diagnostic devices market. A patient can face immobility right after a femoral surgery leading to increased discomfort, as a result, collagen-based closure devices have been implemented. According to a study conducted by the American Journal of Neuroradiology which they surveyed 698 Angio-Seal closures, using the Angio seal reduced the average time before mobilization by close to 15 minutes with no major complications. Angio seal is a type of collagen hemostasis device which reduces the average time of hemostasis and betters the mobilization of the patient.
In 2021, Baxter International Inc., a leading global medical products company, has announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc for up to $60.8 million, as well as $25 million paid upfront. This acquisition helps the transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio. CryoLife, Inc. is one of the world's leading contemporary medical device companies.
The countries covered in the hemostasis diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The hemostasis diagnostic devices and equipment market research report is one of a series of new reports that provides hemostasis diagnostic devices and equipment market statistics, including hemostasis diagnostic devices and equipment industry global market size, regional shares, competitors with a hemostasis diagnostic devices and equipment market share, detailed hemostasis diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hemostasis diagnostic devices and equipment industry. This hemostasis diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the hemostasis diagnostic devices and equipment market are C.R. Bard, Baxter International Inc, Pfizer Inc, Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc, Becton, Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, and F. Hoffmann-La Roche Ltd.
This product will be delivered within 1-3 business days.
Hemostasis diagnostic devices and equipment consists of sales of instruments such as analyzers, coagulation instruments, other hemostasis instruments, and reagents and kits that are used in hemostasis diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
Hemostasis is the process of slowing and stopping the blood flow to initiate wound healing after a vascular injury. With the help of hemostasis diagnostic devices, the cause of bleeding during surgery can be predicted by identifying any hemostatic defects in patients.
North America was the largest region in the hemostasis diagnostic devices and equipment market in 2022. Asia Pacific was the second-largest region in the hemostasis diagnostic devices and equipment market. The regions covered in the hemostasis diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The main products of hemostasis diagnostic devices and equipment are analyzers, coagulation instruments, other hemostasis instruments, and reagents and kits. A hemostasis diagnostic analyzer is a tool utilized to predict the cause of bleeding during surgery by identifying any hemostatic defects. The hemostasis diagnostic devices and equipment are automated, semi-automated, and manual that is used by hospitals, clinics, independent diagnostic, laboratories, and others.
The increased likelihood of older people being diagnosed with a disease is driving the number of surgeries such as cardiovascular diseases (CVD), using hemostasis devices. Due to the higher incidence of diseases with advancing age, there is an increase in the number of surgeries in elderly patients nowadays. These hemostasis devices are very efficient in speeding up the natural process of clotting in the blood and can monitor anticoagulation and transfusion therapy guidance in any surgery.
According to the American Heart Association report, Americans older than 80 have a high risk of devolving a cardiovascular disease (CVD), around 83% of men and 87.1% of females will be suffering from any form of CVD, therefore, to improve the comfort of the patient and the success rate of surgeries as a result hemostasis device has been implemented widely.
The use of hemostasis devices in hospitals or clinics requires a very lengthy approval procedure which is restraining the market. Before hemostasis devices can enter the market for commercial use they have to clear the regulations set by the Code of Federal Regulations (title 21). The process of approval consists firstly identification of the device, secondly classification of the device and finally, the date of the pre-market approval (PMA) or the notice of completion of prescription drug plan (PDP) is required. It is a very long and time-consuming approval process that discourages new entrants from entering this market. For example, Cardiva medical Inc. had to wait for a processing period of four months before they received approval to change the existing equipment with a newer and modern one.
The emergence of new and improved technology in the hemostasis diagnostic device and equipment market. To improve the quality and success rate of operations, new and improved technology such as the collagen vascular hemostasis devices have been implemented. Collagen is the main structural protein found in skin and other connective tissues. It is widely used in purified form for cosmetic surgical treatments and has now emerged in the hemostasis diagnostic devices market. A patient can face immobility right after a femoral surgery leading to increased discomfort, as a result, collagen-based closure devices have been implemented. According to a study conducted by the American Journal of Neuroradiology which they surveyed 698 Angio-Seal closures, using the Angio seal reduced the average time before mobilization by close to 15 minutes with no major complications. Angio seal is a type of collagen hemostasis device which reduces the average time of hemostasis and betters the mobilization of the patient.
In 2021, Baxter International Inc., a leading global medical products company, has announced its Baxter Healthcare Corporation subsidiary has completed the acquisition of certain assets related to PerClot Polysaccharide Hemostatic System from CryoLife, Inc for up to $60.8 million, as well as $25 million paid upfront. This acquisition helps the transaction reinforces Baxter’s strategy of acquiring products and technologies that both complement and augment the company’s leading portfolio. CryoLife, Inc. is one of the world's leading contemporary medical device companies.
The countries covered in the hemostasis diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia.
The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD ($) unless otherwise specified).
The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.
The hemostasis diagnostic devices and equipment market research report is one of a series of new reports that provides hemostasis diagnostic devices and equipment market statistics, including hemostasis diagnostic devices and equipment industry global market size, regional shares, competitors with a hemostasis diagnostic devices and equipment market share, detailed hemostasis diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hemostasis diagnostic devices and equipment industry. This hemostasis diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Major players in the hemostasis diagnostic devices and equipment market are C.R. Bard, Baxter International Inc, Pfizer Inc, Johnson & Johnson, Abbott Laboratories, Beckman Coulter Inc, Becton, Dickinson and Company, Chrono-Log Corporation, CSL Behring LLC, and F. Hoffmann-La Roche Ltd.
This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Hemostasis Diagnostic Devices and Equipment Market
What is the estimated value of the Global Hemostasis Diagnostic Devices and Equipment Market?
What is the growth rate of the Global Hemostasis Diagnostic Devices and Equipment Market?
What is the forecasted size of the Global Hemostasis Diagnostic Devices and Equipment Market?
Who are the key companies in the Global Hemostasis Diagnostic Devices and Equipment Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2023 |
| Forecast Period | 2023 - 2027 |
| Estimated Market Value ( USD | $ 5.4 billion |
| Forecasted Market Value ( USD | $ 8 billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
Table of Contents
1. Executive Summary2. Hemostasis Diagnostic Devices And Equipment Market Characteristics
3. Hemostasis Diagnostic Devices And Equipment Market Trends And Strategies
4. Hemostasis Diagnostic Devices And Equipment Market - Macro Economic Scenario
4.1 COVID-19 Impact On Hemostasis Diagnostic Devices And Equipment Market
4.2 Ukraine-Russia War Impact On Hemostasis Diagnostic Devices And Equipment Market
4.3 Impact Of High Inflation On Hemostasis Diagnostic Devices And Equipment Market
5. Hemostasis Diagnostic Devices And Equipment Market Size And Growth
5.1. Global Hemostasis Diagnostic Devices And Equipment Historic Market, 2017-2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Hemostasis Diagnostic Devices And Equipment Forecast Market, 2022-2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Hemostasis Diagnostic Devices And Equipment Market Segmentation
6.1. Global Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Analyzers
- Coagulation Instrument
- Other Hemostasis Instruments
- Reagents and Kits
- Hospitals
- Clinics
- Independent Diagnostic
- Laboratories
- Other End Users
- Automated
- Semi-Automated
- Manual
7.1. Global Hemostasis Diagnostic Devices And Equipment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
7.2. Global Hemostasis Diagnostic Devices And Equipment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
8. Asia-Pacific Hemostasis Diagnostic Devices And Equipment Market
8.1. Asia-Pacific Hemostasis Diagnostic Devices And Equipment Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.3. Asia-Pacific Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
9. China Hemostasis Diagnostic Devices And Equipment Market
9.1. China Hemostasis Diagnostic Devices And Equipment Market Overview
9.2. China Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
9.3. China Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
10. India Hemostasis Diagnostic Devices And Equipment Market
10.1. India Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
10.2. India Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11. Japan Hemostasis Diagnostic Devices And Equipment Market
11.1. Japan Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
11.2. Japan Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12. Australia Hemostasis Diagnostic Devices And Equipment Market
12.1. Australia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
12.2. Australia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13. Indonesia Hemostasis Diagnostic Devices And Equipment Market
13.1. Indonesia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
13.2. Indonesia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14. South Korea Hemostasis Diagnostic Devices And Equipment Market
14.1. South Korea Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
14.2. South Korea Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15. Western Europe Hemostasis Diagnostic Devices And Equipment Market
15.1. Western Europe Hemostasis Diagnostic Devices And Equipment Market Overview
15.2. Western Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
15.3. Western Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16. UK Hemostasis Diagnostic Devices And Equipment Market
16.1. UK Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
16.2. UK Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17. Germany Hemostasis Diagnostic Devices And Equipment Market
17.1. Germany Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
17.2. Germany Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18. France Hemostasis Diagnostic Devices And Equipment Market
18.1. France Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
18.2. France Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market
19.1. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market Overview
19.2. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
19.3. Eastern Europe Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20. Russia Hemostasis Diagnostic Devices And Equipment Market
20.1. Russia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
20.2. Russia Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21. North America Hemostasis Diagnostic Devices And Equipment Market
21.1. North America Hemostasis Diagnostic Devices And Equipment Market Overview
21.2. North America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
21.3. North America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22. USA Hemostasis Diagnostic Devices And Equipment Market
22.1. USA Hemostasis Diagnostic Devices And Equipment Market Overview
22.2. USA Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
22.3. USA Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23. South America Hemostasis Diagnostic Devices And Equipment Market
23.1. South America Hemostasis Diagnostic Devices And Equipment Market Overview
23.2. South America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
23.3. South America Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24. Brazil Hemostasis Diagnostic Devices And Equipment Market
24.1. Brazil Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
24.2. Brazil Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25. Middle East Hemostasis Diagnostic Devices And Equipment Market
25.1. Middle East Hemostasis Diagnostic Devices And Equipment Market Overview
25.2. Middle East Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
25.3. Middle East Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26. Africa Hemostasis Diagnostic Devices And Equipment Market
26.1. Africa Hemostasis Diagnostic Devices And Equipment Market Overview
26.2. Africa Hemostasis Diagnostic Devices And Equipment Market, Segmentation By Product, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
26.3. Africa Hemostasis Diagnostic Devices And Equipment Market, Segmentation By End User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
27. Hemostasis Diagnostic Devices And Equipment Market Competitive Landscape And Company Profiles
27.1. Hemostasis Diagnostic Devices And Equipment Market Competitive Landscape
27.2. Hemostasis Diagnostic Devices And Equipment Market Company Profiles
27.2.1. C.R. Bard
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Baxter International Inc.
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Pfizer Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Johnson & Johnson
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Abbott Laboratories
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Key Mergers And Acquisitions In The Hemostasis Diagnostic Devices And Equipment Market
29. Hemostasis Diagnostic Devices And Equipment Market Future Outlook and Potential Analysis
30. Appendix
30.1. Abbreviations
30.2. Currencies
30.3. Historic And Forecast Inflation Rates
30.4. Research Inquiries
30.5. About the Publisher
30.6. Copyright And Disclaimer
Executive Summary
Hemostasis Diagnostic Devices And Equipment Global Market Report 2023 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on hemostasis diagnostic devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered
1) By Product: Analyzers; Coagulation Instrument; Reagents and Kits; Other Hemostasis Instruments2) By End User: Hospitals; Clinics; Independent Diagnostic; Laboratories; Other End Users
3) By Device Technology: Automated; Semi-Automated; Manual
Companies Mentioned: C.R. Bard; Baxter International Inc.; Pfizer Inc.; Johnson & Johnson; Abbott Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
A selection of companies mentioned in this report includes:
- C.R. Bard
- Baxter International Inc.
- Pfizer Inc.
- Johnson & Johnson
- Abbott Laboratories
- Beckman Coulter Inc.
- Becton
- Dickinson and Company
- Chrono-Log Corporation
- CSL Behring LLC
- F. Hoffmann-La Roche Ltd.
- Grifols S.A.
- HemCon Medical Technologies Inc.
- Integra Life Sciences Corporation
- Medtronic plc
- Siemens AG
- Thermo Fisher Scientific Inc.
- Trinity Biotech plc.
- Ethicon
- Boston Scientific
- Olympus
- Medtronic
- Cook Medical
- Halyard
- Medline
- Pentax
- ConMed
- Fujinon
- Moog
Methodology
LOADING...
